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1078–5884/00A Randomized Prospective Study of Valvulotome Efficacy in
In situ Reconstructions
J. Malmstedt,* R. Takolander and E. WahlbergDepartment of Vascular Surgery, Karolinska University Hospital, Stockholm, SwedenObjectives. To compare the efficacy of valvulotomes during in situ bypass surgery.
Design. A randomized prospective blinded study.
Materials and methods. Thirty PAD patients scheduled for infrainguinal greater saphenous vein bypass were randomized
to use of adjustable or fixed valvulotomes for valve destruction. Valvulotomy was performed after construction of the
proximal anastomosis. The efficacy of valve destruction was determined by angioscopy after completion of the distal
anastomosis by a separate blinded examiner.
Results. A total of 123 valves were evaluated, 61 after use of an adjustable and 62 with a fixed valvulotome. There was no
difference (pZ.88) in number of retained valves between the two groups (nZ16, 17, respectively). The majority of
incompletely destroyed valves were found in the proximal parts of the graft (46%, 13 out of 28). The primary patency at 30
days was 100 and 79%, respectively, pZ.09).
Conclusions. No significant difference in efficacy between valvulotomes was found. Both types tend to miss a large
proportion of proximal valves.Keywords: Valvulotomy; In situ bypass grafts; Vascular reconstruction; Infrainguinal bypass.Infrainguinal reconstruction using the in situ tech-
nique for preparation of the saphenous vein was first
described by Hall 19641 and further developed by
Leather.2 With this technique, total valve disruption is
probably essential for achieving good results. Despite
this goal, residual valve cusps are reported to occur
with frequencies between 12 and 45% after in situ
bypass surgery.3–7 Up to 15% of early graft failures are
caused by residual valves,8–10 therefore, it is important
that there are improvements in valve destruction
techniques. Especially, when considering the fact that
the limb salvage and patency rates after reoperation
due to early graft failure are poor,11,12 and secondary
procedures to assist patency are associated with
considerable morbidity.13,14
One development to facilitate valve destruction and
improve patency is the adjustable valvulotome (AV).7,15
With fixed size valvulotomes it is difficult to accom-
plish adequate valve destruction in the proximal parts
of the vein3 and there is a substantial risk of
endothelial damage.4,16–18 The AV is designed to
accomplish good valve destruction in the relativelying author. Jonas Malmstedt, MD, Department of
ery, Karolinska University Hospital, 171 76 Stockholm,
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damage to the endothelium in the distal part.
Theoretically this improvement should be favourable
and may decrease the rate of residual valve cusps, but
has to our knowledge never been evaluated
thoroughly. The purpose of this study was, therefore,
to evaluate and compare the effectiveness of AV and
fixed valvulotome (FV) valve destruction.Materials and MethodsPatients
Thirty patients scheduled for infrainguinal in situ
bypass surgery with the great saphenous vein (GSV) at
the Karolinska Hospital were randomized to use of
either AV or FV. Patients were included between
October 2000 and April 2004. Patients were included if
they consented to participate and an experienced
angioscopist was available. Patient characteristics,
indication for surgery and type of procedure are
shown in Tables 1 and 2. Patients underwent pre-
operative angiography, duplex vein mapping and a
clinical examination, including ankle brachial indexEur J Vasc Endovasc Surg 30, 52–56 (2005)
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Table 1. Patient characteristics
Characteristic Valvulotome
AV (nZ15) FV (nZ15) p*
Men/women
(n)
5/10 7/8 .71
Age median
(range)
75 (52–86) years 77 (55–85) years .97
Preop ABI
median (range)
0.24 (0.00–0.62) 0.40 (0.13–0.69) .12
Diabetes (n) 3 7 .26
Smoking (n) 9 7 .71
Hyperlipidemia
(n)
9 9 1.00
Heart disease
(n)
8 7 1.00
Hypertension
(n)
11 9 .70
Renal failure (n) 1 1 1.00
Stroke (n) 2 5 .39
Previous vascu-
lar surgery (n)
5 6 1.00
COPD (n) 3 3 1.00
ABI, arterial ankle-brachial index; COPD, chronic obstructive
pulmonary disease.
* Fischer’s test, except for age and preoperative ABI where Mann–
Whitney U test are used.
Residual Values Common after Valvulotomy 53(ABI) measurements. They were followed up accord-
ing to hospital routines. This included clinical exam-
ination at one month and duplex scanning at 1, 3 and 6
months postoperatively.Surgery
The procedures were performed under epidural
anaesthesia. In brief, arteries were accessed using a
groin and an appropriate distal incision to expose the
outflow vessel. Proximally, the GSV was divided at the
confluence and the most proximal pair of valves wasTable 2. Indication for surgery, type of procedure and preoperative v
Valvulotome
AV (nZ15)
Rutherford category19
Severe claudication 2
Ischemic rest pain 6
Minor ulcer 6
Major ulcer 1
Type of surgery
Femoro-popliteal AK 4
Femoro-popliteal BK 6
Femoro-crural 5
Vein diameter [mm]
Proximal median (range) 4.3 (3.5–8.0)
Distal median (range) 2.3 (1.9–5.3)
Smallest segment median
(range)
2.2 (1.7–4.6)
AK, above knee; BK, below knee.
* Chi-square test.
† Mann–Whitney U test.excised under direct vision by scissors. Patients were
heparinized with 2500–5000 IU Heparin intrave-
nously. The proximal anastomosis was constructed in
an end-to-side manner to the common femoral artery
using a running suture. The vein was then exposed to
arterial pressure and the distal part of the vein was
exposed. At that time patients were allocated either to
use of a AV (Expandable LeMaitre valvulotomew,
LeMaitre Vascular, USA) or a FV (Insitucatw, B. Braun
Melsungen, Germany). The diameter of the largest
head (2.5 or 3.0 or 3.5 mm) of FV used, the number of
times the valvulotome was passed through the vein
and the surgeon’s estimation of graft flow (poor, fair,
very good) after valvulotomy were registered. The
distal anastomosis was constructed similar to the
proximal anastomosis. GSV branches were identified
preoperatively by handheld Doppler in addition to
preoperative marking by Duplex and ligated. Finally
angioscopy was performed through a spared side
branch in the most proximal part of the vein. This was
done by a separate blinded examiner not participating
in the operation using a flexible 2.4 mm angioscope
(Intramedw Reusable Angioscope, Baxter Healthcare
Corporation, USA). The graft was inspected during
flushing with warm Ringer solution administrated by
a mechanical infusion pump controlled by a foot pedal
(Intramed Endoscopic Irrigation Pumpw, Baxter
Healthcare Corporation, USA) at 80–250 ml/s. Arterial
inflow was occluded during angioscopy. The angio-
scope was passed all the way to distal anastomosis and
the inspection of the graft was performed while
retracting the scope. Identified retained valves were
cut by a Mill valvulotome, and missed side-branches
that were found during angioscopy were marked and
ligated.ein mapping data
FV (nZ15) p
3 .19*
1
10
1
3 .75*
5
7
4.7 (2.5–6.1) .37†
2.7 (2.0–4.3) .50†
2.5 (2.0–3.5) .64†
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The study was approved by the local ethics committee.
Patency and indications for surgery were defined
according to Rutherford.19 Closed envelopes were
used for randomization. Three vascular surgeons who
were internally validated performed all angioscopies
and assessed valvulotomy efficacy. The number and
location of valves cut and the effectiveness of valvular
destruction were recorded. A scale with three grades
was used: missed, partially cut or completely cut as
shown in Fig. 1. The definitions were as follows: a
missed valve was defined as both cusps cut no more
than half. A completely cut valve was defined as both
cusps cut more than half the way to the vein wall. A
partially cut valve was defined as conditions between
missed and completely cut. For the analysis the partial
and missed groups were combined and named
‘incomplete’. The primary endpoint for the study
was the number of insufficiently cut valves (missed or
partially cut). A secondary endpoint was patency at
follow-up.Statistics
Differences in categorial variables between groups
were analyzed by Chi-square and Fisher’s exact test.
Continuous variables were evaluated by Mann–Whit-
ney test. Results with P!0.05 was considered signifi-
cant. One person (JM) performed all the analyses after
completion of the study.valve cusp
Completely cut 
(examples) 
Partially cut
(examples) 
Missed
(examples) 
Fig. 1. Definitions of valve destruction efficacy used during
angioscopy assessment. (The hatched lines represent half the
cusp diameter).
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Fifteen patients were randomized to each group but
one from each was excluded from the analysis of the
primary endpoint due to failure of the angioscopy
instrument. There were no statistical significant
differences in risk factors, indication, or type of
surgery between groups (Tables 1 and 2). Estimated
graft flow was considered as fair or very good in all
patients after valvulotomy, but to achieve that the
valvulotomes needed to be passed through the vein
slightly more times in the FV group (median 3.2, range
2–6 vs. median 2.5, range 2–3 times, pZ.09). Two
valvulotome related complications occurred, both in
the FV group. One was a perforation of the vein wall
adjacent to a branch and the other an intramural
haematoma (and early occlusion) due to vein damage,
which probably was caused by the valvulotome.
Sixty-one valves were assessed in the AV group and
62 in the FV group. The proportion of incompletely cut
valves was similar (pZ.88) between the valvulotomes
(AV 26%, nZ16 vs. FV 27%, nZ17) (Table 3). The
majority of missed cusps were located proximally (Fig.
2). It was slightly more common to have an incomple-
tely cut proximal valve in the AV group (57% 8/14 vs.
36% 5/14) but the difference was not statistically
different (pZ.22). The location of incompletely cut
valves is depicted in Fig. 2.
Primary patency at 30 days was 89% (Table 4),
(100% 12/12 in AV group and 79% 11/14 in FV group,
pZ.09). There were three occlusions within 5 days in
the FV group, one of these were probably related to
vein damage by the valvulotome. This graft was
successfully reopened. One patient in the AV group
died with a patent graft 24 days after surgery due toTable 3. Results, valve disruption and graft flow assessment by the
surgeon
Valvulotome
Total AV
(nZ14)*
FV
(nZ14)*
p
Inspected valves 123 61 62
Complete 90 45 45 .88†
Incomplete 33 16 17
Missed valves 4 3 1 .26†
Partially cut 29 13 16
Number of graft
passings
Mean
(range)
2.5 (2–3) 3.2 (2–6) .09‡
Flow (nZ15)* (nZ15)*
Fair 6 2 4 .36†
Very good 22 13 11
Poor 0 0 0
* Number of patients. One patient omitted from each group due to
angioscopic failure.
† Chi-square test.
‡ Mann–Whitney U test.
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Fig. 2. Location of incompletely cut valves. (The first
(proximal) valve was cut with a pair of scissors under direct
vision).
Residual Values Common after Valvulotomy 55congestive heart failure and another patient, also in the
AV group died after 30 days due to pulmonary
oedema and multiple organ failure. There was one
minor amputation in the AV group and two major
amputations (one in the FV and one in the AV group)
within 30 days. Midgraft stenoses, a marker of
suspicious valve remnants, were detected with duplex
scanning in one graft in the AV group and two grafts in
the FV group. The stenoses were detected after 76, 72
and 213 days, respectively. One of these grafts in each
group occluded after 221 and 388 days, respectively.
At a mean follow-up of 224 days the primary patency
was 69% (80% the AV and 58% in the FV group, pZ
.40).Discussion
The principal finding in this study is the similarity of
AV and FV valve destruction efficiency. The outcome
data is extremely unreliable due to few cases and
incomplete follow-up. The number of valve remnants
in the grafts during follow-up was similar. While this
study may have missed minor differences in efficacy
due to lack of power, we believe that the results are by
large valid. There are several possible explanations for
the findings. The fact that most missed valves areTable 4. Primary patency life table
Interval
(months)
No. at risk at
beginning of
interval
No. failed
during interval
Withdraw
during in
0–1 30 3 4
1–3 23 1 3
3–6 19 1 2
6–9 16 2 4
9–12 10 0 2
* Calculated according to Rutherford.19found in the proximal part of the graft indicates that
the vein diameter may be important. The diameter
may particularly influence the results of AV use
because retained valves tended to be more common
with this valvulotome proximally. The maximum
diameter of the AV hoop is 8 mm and the blade
6 mm. This may be too small for effective valve
disruption in a wide vein. Our preoperative vein
mapping data showed proximal vein diameters
around 6–8 mm, which may become wider when the
vein is put under arterial pressure. An important
difference between the FV and AV is the size of the
cutting blade. In the latter it is only about 1 mm
whereas it equals the outer diameter (2.5–3.5 mm) in
the former. This implies that the AV may cut only a
small part of the valve cusp in a wide vein. On the
other hand, the FV is designed to cut the cusp all the
way to the vein wall aided by manual steering;20
whereas the lack of centering mechanism will increase
the risk of only cutting one of the two cusps in a wide
vein. Another possible explanation to our results is
that some of our veins may have valvular insufficiency.
With the centered AV blades there is a substantial risk
that less than half of the two cusps are cut.
The proportion of residual valve cusps (27%) in our
patients is comparable to previous data from studies
using either AV or FV assessed by angioscopy.3,5,6,16,21
Ahlba¨ck et al. also noted that most missed valves (29%)
were found in the proximal part of the vein when
using an FV.3 Thorne et al. used the same AV as in this
study and reported residual valve cusps detected in
half (17/32) of the patients, with a mean of two
residual cusps per graft.21 Substantially fewer grafts
with retained valves were found by Dardik.7 He also
evaluated the same AV and found missed valves in
only 2 of 25 grafts, as compared to our data where 12 of
14 grafts had retained valves. In that study, however,
the number of valves inspected or the number of
incomplete cut valves were not reported. The dis-
crepancy in results may be due to differences in
definitions of residual valves. Furthermore, this study
was performed in 11 different centers, adding a
substantial risk of interobserver variability. None ofn
terval
Interval failure
rate*
Cumulative
patency rate* (%)
Standard error*
(%)
0.107 89 2.96
0.047 85 3.69
0.056 80 4.21
0.143 69 4.29
0.000 69 6.87
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tome efficacy.
Accordingly our findings correspond to, and sup-
port most previous non-randomized studies. Together
they suggest that complete valve disruption without
endothelial damage is difficult to achieve and prob-
ably needs improvement. A proposed alternative to
blind valvulotomy is to use the angioscopy-assisted
technique.10,22 The question whether insufficient valve
destruction actually will affect patency could not be
answered by this study, but a previous report indicate
that it does.21 Our attempt to compare patency rates is
flawed by the small patient cohort and the correction
of identified missed valves after angioscopy. The low
frequency of valve remnants during follow-up also
make it difficult to draw conclusions about valve
remnants influence on graft function. The two major
valvulotomy complications occurred in the FV group,
but those may have happened by coincidence. That AV
may cause less graft damage is plausible but not well
supported in the literature.
In conclusion, insufficiently destroyed valves are
very common but there is no large difference in
efficacy between FV and AV. The latter valvulotome
appears to overlook at least as many proximal valves
as FV. There is a great need for further improvements
in valvulotomy design and usage.Acknowledgements
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